Osaka City University, abbreviated to Ichidai or Shidai, is a public university in Japan. It is located in Sumiyoshi-ku, Osaka. It is one of the most prestigious universities in Japan regarding Applied Linguistics.

During the past decade, Osaka City University conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Osaka City University" #1 sponsor was "Wakayama Medical University" with 3 trials, followed by "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored, "Nanfang Hospital of Southern Medical University" with 1 trials sponsored, "Neonatal Encephalopathy Consortium, Japan" with 1 trials sponsored and "Osaka City University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka City University" #1 collaborator was "Osaka City University" with 2 trials as a collaborator, "Ankara University" with 1 trials as a collaborator, "Beijing 302 Hospital" with 1 trials as a collaborator, "Beijing Tsinghua Changgeng Hospital" with 1 trials as a collaborator and "Chulalongkorn University" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Osaka City University" are "Sarcoma" (2 trials), "Compensated Liver Cirrhosis" (1 trials), "Gastroesophageal Varices Bleeding" (1 trials), "Head and Neck Cancer" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Osaka City University" in a lesser frequency.

Most popular intervention types in "Osaka City University" are "Drug" (6 trials), "Biological" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "dactinomycin" (2 trials), "vincristine sulfate" (2 trials), "Autologous umbilical cord blood cells" (1 trials) and "Conventional procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osaka City University" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Osaka City University". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Osaka City University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osaka City University, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Osaka City University has several departments that took part in Clinical trials: "Department of Gastroenterology, Osaka City University Graduate School of Medicine" - 2 trials